Adverse drug reactions of montelukast in children and adults

Open Access
Creative Commons


Pharma Res Per, 5(5), 2017, e00341

Meindina G. Haarman, Florence van Hunsel, Tjalling W. de Vries

Abstract

Montelukast, a selective leukotriene receptor antagonist, is recommended in guidelines for the treatment of asthma in both children and adults. However, its effectiveness is debated, and recent studies have reported several adverse events such as neuropsychiatric disorders and allergic granulomatous angiitis. This study aims to obtain more insight into the safety profile of montelukast and to provide prescribing physicians with an overview of relevant adverse drug reactions in both children and adults. We retrospectively studied all adverse drug reactions on montelukast in children and adults reported to the Netherlands Pharmacovigilance Center Lareb and the WHO Global database, VigiBase® until 2016. Depression was reported most frequently in the whole population to the global database VigiBase® (reporting odds ratio (ROR) 6.93; 95% CI: 6.5–7.4). In the VigiBase®, aggression was reported the most in children (ROR, 29.77; 95% CI: 27.5–32.2). Headaches were reported the most frequently to the Dutch database (ROR, 2.26; 95% CI: 1.61–3.19). Furthermore, nightmares are often reported for both children and adults to the Dutch and the global database. Eight patients with allergic granulomatous angiitis were reported to the Dutch database and 563 patients in the VigiBase®. These data demonstrate that montelukast is associated with neuropsychiatric adverse drug reactions such as depression and aggression. Especially in children nightmares are reported frequently. Allergic granulomatous angiitis is also reported, a causal relationship has not been established.

PDF

 

(You must be logged in to add and reply comments)

Interasma on Twitter

Interasma RT @worldallergy: WAO TV: Newer technologies to treat allergies and asthma - January 2019. Pinkus Goldberg, MD, Allergy Partners & Indiana…
1hreplyretweetfavorite
Interasma RT @Aller_MD: Enterovirus as trigger of coeliac disease: Enterovirus in early childhood could be a trigger for later coeliac disease in chi…
1hreplyretweetfavorite
Interasma RT @Aller_MD: Top story: Anaphylaxis Treatment: How to Avert This Severe Allergic Reaction | Everyday Health https://t.co/8AM98iAzzn, see m…
1hreplyretweetfavorite
Interasma RT @Aller_MD: “IMAGES IN CLINICAL MEDICINE: Sporotrichosis” https://t.co/Tbcl83VSUT https://t.co/v882YVbh8v
1hreplyretweetfavorite
Interasma Interasma - Association of plasma soluble CD14 level with #asthma severity in adults: a case control study in China https://t.co/OCQ2S7Z22e
1hreplyretweetfavorite

Editor: Juan C. Ivancevich, MD

Copyright © Interasma 2003-2017  •  Terms of Use  •  Privacy Policy  •  Contact Us  •  Sitemap

Powered by FREI SA

InterAsma